UHN-developed cell lines, biomaterials and research resources are helping researchers, innovators and industry partners advance the next generation of healthcare solutions.

From drug discovery and disease modelling to cell therapy and translational research, these valuable scientific assets support a wide variety of research and development activities across a wide range of health and life sciences applications.

Cell Lines
‍

Biomaterials and
reagents

Disease models
‍

Contact: commercialization@uhn.ca to learn more.

AI & Digital Health Platforms

the future of healthcare

Our innovative solutions harness the power of futuristic AI, machine learning, software, planning and automation technologies to improve the efficiency, quality and delivery of healthcare.

Drug Discovery, Delivery & Screening

Inspiring Progress

We translate cutting-edge research in genetic therapies, biologics, new molecules, biomarkers and more into progressive, proven solutions with the potential to change the face of healthcare.

Diagnosing Disease

speed, accuracy and customization

By speeding the next generation of diagnostic tools into the hands of the medical community, we’re driving more timely and accurate diagnostic results for all and are increasingly able to customize advanced personalized medicine options for patients.

Medical Devices

endless possibilities

We combine expert research and the latest technological advancements to create cutting-edge commercialized medical devices.

Repository of Clinical Tools, Cell Lines and Other Biomaterials

sharing for success

A robust repository of clinical tools, cell lines and other materials are available for academic and industry partnership alike. Featuring screening tools such as the STOP-Bang questionnaire, helping with North American patient  screening for OSA (obstructive sleep apnea), many of our solutions are internationally renowned and adaptable in multiple settings.